Godavari Drugs Ltd
GODAVARIGodavari Drugs Ltd
GODAVARI
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 14.06 | 2.38 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Godavari Drugs is engaged in the contract manufacturing, loan license manufacturing, manufacturing and supply of active pharmaceutical ingredients (APIs), drug intermediaries and fine chemicals
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 71.31 | 76.40 | 65.13 | 83.78 | 96.03 | 123.08 | 161.39 | 160.50 | 157.33 | 140.98 | ||||||||||
Raw Materials | 56.95 | 63.25 | 48.18 | 66.95 | 77.38 | 94.15 | 127.97 | 137.82 | 121.95 | 126.01 | ||||||||||
| Power & Fuel Cost | 2.71 | 4.57 | 3.98 | 4.20 | 4.84 | 4.76 | 5.46 | 6.66 | 8.51 | |||||||||||
| Employee Cost | 2.17 | 2.38 | 2.67 | 3.45 | 3.45 | 3.94 | 4.96 | 4.84 | 5.13 | |||||||||||
| Selling & Administrative Expenses | 0.96 | 0.96 | 0.98 | 0.91 | 1.29 | 1.24 | 1.38 | 1.27 | 1.50 | |||||||||||
| Operating & Other expenses | 3.84 | -0.78 | 4.60 | 2.56 | 2.70 | 8.74 | 10.04 | -0.88 | 6.41 | |||||||||||
EBITDA | 4.68 | 6.02 | 4.72 | 5.71 | 6.37 | 10.25 | 11.58 | 10.79 | 13.83 | 14.97 | ||||||||||
| Depreciation/Amortization | 0.63 | 0.81 | 0.99 | 1.09 | 1.16 | 1.22 | 1.70 | 1.94 | 1.99 | 2.16 | ||||||||||
| PBIT | 4.05 | 5.21 | 3.73 | 4.62 | 5.21 | 9.03 | 9.88 | 8.85 | 11.84 | 12.81 | ||||||||||
| Interest & Other Items | 1.88 | 2.51 | 2.42 | 2.89 | 2.91 | 3.32 | 2.85 | 3.93 | 4.92 | 5.02 | ||||||||||
| PBT | 2.17 | 2.70 | 1.31 | 1.73 | 2.30 | 5.71 | 7.03 | 4.92 | 6.92 | 7.79 | ||||||||||
| Taxes & Other Items | 0.83 | 0.89 | 0.49 | 0.54 | 0.29 | 1.58 | 1.78 | 1.15 | 1.38 | 1.19 | ||||||||||
| Net Income | 1.34 | 1.81 | 0.82 | 1.19 | 2.01 | 4.13 | 5.25 | 3.77 | 5.54 | 6.60 | ||||||||||
| EPS | 1.78 | 2.40 | 1.09 | 1.58 | 2.67 | 5.48 | 6.97 | 5.01 | 7.36 | 8.76 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Godavari Drugs Ltd | 16.75 | 2.38 | — |
| Sun Pharmaceutical Industries Ltd | 45.35 | 6.47 | 0.75% |
| Cipla Ltd | 28.51 | 4.38 | 0.89% |
| Torrent Pharmaceuticals Ltd | 68.45 | 16.54 | 0.84% |
Price Comparison
Compare GODAVARI with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
GODAVARI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet profit of Godavari Drugs rose 26.74% to Rs 1.09 crore in the quarter ended September 2024 as against Rs 0.86 crore during the previous quarter ended September 2023. Sales declined 34.02% to Rs 26.09 crore in the quarter ended September 2024 as against Rs 39.54 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales26.0939.54 -34 OPM %11.127.76 - PBDT1.831.77 3 PBT1.251.28 -2 NP1.090.86 27 Powered by Capital Market - Live
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Net profit of Godavari Drugs rose 101.23% to Rs 1.63 crore in the quarter ended June 2024 as against Rs 0.81 crore during the previous quarter ended June 2023. Sales declined 9.06% to Rs 32.21 crore in the quarter ended June 2024 as against Rs 35.42 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales32.2135.42 -9 OPM %10.036.35 - PBDT2.561.59 61 PBT2.011.12 79 NP1.630.81 101 Powered by Capital Market - Live
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Godavari Drugs Standalone March 2022 Net Sales at Rs 44.28 crore, up 34.35% Y-o-Y
Godavari Drugs standalone net profit declines 1.55% in the March 2022 quarter
Godavari Drugs standalone net profit rises 67.06% in the June 2021 quarter
Godavari Drugs Standalone March 2021 Net Sales At Rs 32.96 Crore, Up 34.87% Y-o-Y
Godavari Drugs standalone net profit rises 69.74% in the March 2021 quarter
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 13.43%, vs industry avg of 9.03%
Constant Market Share
Over the last 5 years, market share stayed at 0.04%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 36.02%, vs industry avg of 15.27%